The high ACSL4/low GPX4 profile holds significant practical value in predicting pathological complete response to neoadjuvant chemotherapy in breast cancer.A strategy to enhance chemosensitivity through the induction of ferroptosis has been identified. Here, ACSL4 is linked to breast cancer.